The year in cardiology: imaging. The year in cardiology 2019. by Pennell, D. et al.
48
IMAGING
This year, artificial intelligence and machine learning applied to 
cardiac imaging has been one of the main novelties. Other 
advances in non-invasive cardiac imaging published in 2019 are 
summarised in this Year in Cardiology review article (Figure 1).
ECHOCARDIOGRAPHY
Early detection of left ventricular (LV) dysfunction in various 
populations has been the focus of numerous publications in 
2019. Left ventricular diastolic function usually precedes LV 
systolic dysfunction and is associated with cardiovascular mor-
bidity and mortality. From the Copenhagen City Heart Study, 
a population-based study including 6 238 individuals, Lassen, 
et al.(3)  evaluated the association between LV filling pressures 
measured on tissue Doppler imaging (E/E’) and speckle tracking 
echocardiography (E/E’sr) with the occurrence of cardiovas-
cular death, admission for incident heart failure or myocardial 
infarction (MI). Of 1 238 participants, 140 (11.3%) reached the 
primary endpoint during a median follow-up of 11 years. After 
adjusting for various clinical and echocardiographic para-
meters, E/E’sr was independently associated with the endpoint 
[hazard ratio (HR) 1.08, 95% confidence interval (CI) 1.02 - 
1.13 per each 10 cm increase; p=0.003], whereas E/E’ was not. 
In addition, E/E’sr provided incremental prognostic value over 
the SCORE risk chart, currently used to evaluate the risk of 
cardiovascular morbidity and mortality in the general popula-
tion. Increased LV filling pressures may reflect the ageing 
process of the heart characterised by increased fibrosis. This 
fibrosis may lead to conduction abnormalities that influence 
the contractile function of the LV. Modin, et al.(4) evaluated in 
1 138 participants of the Copenhagen City Heart Study the 
prognostic value of LV mechanical dispersion, which is mea-
sured as the standard deviation from time to peak longitudinal 
strain of the three LV apical views. The mean value of LV 
mechanical dispersion in the general population was 45 ± 38ms 
and increased with age, hypertension, body mass index, and 
presence of MI. Large LV mechanical dispersion was associ-
ated with worse LV systolic and diastolic function. Each 10ms 
increase in LV mechanical dispersion was independently asso-
ciated with increased risk of cardiovascular death (HR 1.04, 
95% CI 1.01 - 1.06; p=0.004).
INTRODUCTION
Multimodality imaging and artif icial intelligence applied to 
imaging techniques have been a major interest in this year. The 
pathophysiological insights that various imaging modalities have 
provided in numerous clinical scenarios (heart failure, coronary 
artery disease, and valvular heart disease) influence the way we 
evaluate and manage patients. Conventional imaging to assess 
cardiac structure and function is still the f irst approach to 
evaluate patients and decide the management. However, 
advanced echocardiography with strain imaging techniques, 
tissue characterisation with cardiovascular magnetic resonance 
(CMR), and assessment of biological processes with nuclear 
imaging techniques have helped to understand that early 
intervention may be needed in order to prevent or halt the 
progression of the disease. By applying machine learning tech-
niques to all these imaging modalities, we are able to generate 
algorithms that can identify certain patterns of disease or risk 
and develop decisions in a more personalised way. This Year in 
Cardiology review articles summarise the most relevant studies 
in the field of imaging published in the last year.
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Despite the growing evidence on the diagnostic and prognostic 
value of strain-derived measures of LV systolic and diastolic 
function, LV ejection fraction (EF) remains the mainstay para-
meter for risk stratification in clinical practice. The association 
between physician-reported LVEF and survival was assessed in 
403 977 echocardiograms performed in 203 135 patients from 
the USA.(5) Fifty percent of the population had an LVEF between 
55% and 65%. Over a median follow-up of 4 years, 23% of 
patients died. A U-shaped relationship between LVEF and all-
cause mortality was observed with the nadir at the 60% - 65% 
LVEF category. These results were reproduced in an inde-
pendent dataset from New Zealand, including 45 531 echo-
cardiograms from 35 976 patients. The U-shaped relationship 
was also observed in men and women, inpatients and out-
patients with heart failure, and deviations from LVEF of 60% - 
65% were associated with greater multiplicative increase in risk 
for younger patients as compared to old patients.
Left ventricular ejection fraction is also the parameter to clas-
sify heart failure patients. Ten to 20% of patients with heart 
failure with reduced LVEF (≤40%) may improve in LVEF. 
However, the evidence on the frequency and outcomes of 
patients with heart failure and recovered LVEF is based on a 
selected cohort of patients or randomised clinical trials. Of 
3 124 heart failure patients with reduced LVEF at baseline 
treated with contemporary heart failure medications, 37.6% 
presented improvement in LVEF from 26% - 46% over a 
median follow-up of 17 months.(6)  Patients with heart failure 
and recovered LVEF had lower rates for all-cause mortality, all-
cause hospitalisations, cardiac transplantation, or LV assist 
device implantation than the patients who remained with 
reduced LVEF. Not less important is the characterisation of 
the right ventricular (RV) remodelling in heart failure patients. 
In 271 patients with heart failure and preserved LVEF (HFpEF), 
RV fractional area change reduced by 10% and RV diastolic area 
increased by 21% over a median follow-up of 4 years.(7) These 
changes exceeded the corresponding changes in the LV. In 
addition, the prevalence of tricuspid regurgitation increased 
by 45%. Atrial fibrillation, higher body weight, coronary artery 
disease, higher pulmonary pressures and LV filling pressures 
and RV dilation were associated with development of RV dys-
function (Figure 2).(7) Patients with HFpEF developing RV dys-
function had a two-fold increased risk of death. In this group of 
heart failure patients, assessment of left atrial function has 
provided important new insights. In 308 patients with HFpEF, 
Freed, et al.(8) showed that impaired left atrial reservoir strain 
(stiff left atrium) was associated with increased pulmonary 
vascular resistance and decreased peak oxygen consumption 
and was independently associated with the composite out-
FIGURE 1: Multimodality imaging and artificial intelligence in cardiac imaging.
The use of the different imaging modalities should be based on a clinical question. Selecting the most appropriate imaging techniques and 
integrating them to answer that specific question will be key to improve the outcomes of patients (A). In the future, many of the processes the 
clinicians are used to doing to integrate all the information gathered from the imaging modalities may be automated by using artificial intelligence 
techniques. How artificial intelligence interacts with medical research, clinical practice and statistics will be the focus of ongoing research (B). 






























come of cardiovascular hospitalisation or death. It should be 
noted that the study did not correct the association between 
left atrial reservoir strain and the composite outcome for 
neuro-hormonal markers, and, as acknowledged by the authors, 
the studies establishing the reference values of normal left atrial 
strain values across the echocardiographic systems and analysis 
platforms are scarce.
In patients with asymptomatic severe aortic stenosis and 
preserved LVEF, LV global longitudinal strain (GLS) on speckle 
tracking echocardiography is more sensitive than LVEF to 
identify early changes in LV systolic function during the follow-
up. An LV GLS of >-18.2% (more impaired) is associated with 
higher risk of developing symptoms and needing aortic valve 
intervention as compared to more preserved values of LV GLS 
(≤-18.2%).(9) Echocardiography is the imaging technique of first 
choice to assess valvular heart disease. Secondary mitral regur-
gitation quantification remains challenging. In 423 heart failure 
patients, Bartko, et al.(10) developed a unifying algorithm com-
bining effective regurgitant orifice area (EROA), regurgitant 
volume, and regurgitant fraction that had better discrimination 
power to identify patients with increased mortality risk than 
current guideline-based definitions. Low-risk patients were 
characterised by an EROA of <20mm2 and a regurgitant volume 
of <30 mL, whereas high-risk patients were defined by an 
EROA of ≥30mm2  and a regurgitant volume of ≥45 mL. 
Intermediate-risk patients (with an EROA between 20 and 
29mm2 and a regurgitant volume of 30 - 44 mL) were reclas-
sified as high risk if the regurgitant fraction was ≥50%. How-
ever, this algorithm had a rather modest discrimination power 
(area under the curve 0.63).
The use of transthoracic focused cardiac ultrasound (FoCUS) is 
gaining popularity at the emergency department and intensive 
care units. Among 839 patients with suspected acute aortic 
syndrome, an aortic dissection detection risk score of ≤1 and a 
negative FoCUS could rule out an acute aortic syndrome with 
a sensitivity of 94% and a failure rate of 1.9%.(11)
FIGURE 2: Development of right ventricular dysfunction (RVD) over time in patients with heart failure and preserved 
ejection fraction.
Increased left ventricular (LV) filling pressures and associated comorbidities characterize the initial phase of isolated left ventricular dysfunction 
(LVD) and lead to right ventricular (RV) remodelling, and right ventricular dysfunction. Patients with incident right ventricular dysfunction have 
a worse outcome as compared to patients with preserved RV function. Reproduced with permission from Obokata, et al.(7)
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Finally, elevated carotid artery wave intensity measured on 
Duplex Doppler ultrasound was independently associated with 
faster cognitive decline among 3 191 individuals enrolled in the 
Whitehall II study,(12)  highlighting the relevance of ultrasound 
imaging outside the heart.
CARDIOVASCULAR MAGNETIC RESONANCE
The ICELAND-MI study is providing significant new data in the 
understanding of MI and fibrosis in elderly adults. In the first 
report by Shanbhag, et al.,(13) 397 patients aged 72 - 81 years 
were studied using CMR incorporating late gadolinium en-
hancement (LGE) imaging, which identifies myocardial fibrosis 
due to MI (subendocardial) and other causes (other patterns). 
During the follow-up of 5.8 years, 192 events were recorded. 
The authors found that major non-ischaemic fibrosis was the 
only independent predictor of outcome (Figure  3).(13)  In the 
second report from the ICELAND-MI trial, Acharya, et al.(14) 
report on the long-term predictive value of unrecognised MI 
(UMI) in an elderly cohort of 935 subjects aged 67 - 93 years. 
Previous reports have suggested a poor short-term prognosis, 
but this study extends follow-up to 13.3 years. The authors 
showed that all-cause mortality in UMI patients was lower than 
recognised MI for at least 5 years, but similar at 10 years. At all 
time-points, UMI had a higher mortality than patients with no 
MI. It is not known whether secondary prevention would be 
useful in UMI patients.
Cardiovascular magnetic resonance has made an enormous 
contribution to the diagnosis and management of the cardio-
myopathies through the presence and patterns of myocardial 
fibrosis from LGE imaging, tissue characterisation through T1, 
T2, and T2* mapping, and accurate measures of ventricular 
function and mass. Gutman, et al.(15) studied 452 patients with 
non-ischaemic dilated cardiomyopathy (DCM) stratified by 
the presence or absence of non-ischaemic myocardial fibrosis 
by LGE. In patients with fibrosis, the mortality was reduced by 
an implantable cardioverter-defibrillator (ICD) with HR 0.45 
(p=0.003), but in patients without f ibrosis there was no 
improvement in mortality with ICD (HR 1.22,  p=0.64). The 
authors conclude that in non-ischaemic DCM, the presence of 
fibrosis may allow for improved selection of patients requiring 
ICD. Galan-Arriola, et al.(16)  used serial CMR to identify the 
early stages of anthracycline-induced cardiotoxicity in a pig 
study. The earliest detectable abnormality was increased T2 
relaxation, which was correlated on histology with intramyocyte 
oedema, without change in the extracellular space. Changes in 
T1 and the extracellular volume on T1 mapping occurred much 
later and coincided with wall motion abnormalities. Stopping 
doxorubicin upon detection of T2 abnormality resolved intra-
FIGURE 3: Inverse propensity adjusted prognosis of ischaemic and non-ischaemic myocardial fibrosis.















































Subject characteristics* → CMR fibrosis →
Ischaemic LGE vs. no LGE HR 1.4; 0.9 - 2.1, p=0.10
Minor non-ischaemic LGE vs. no LGE HR 1.2; 0.8 - 1.8, p=0.39
Major non-ischaemic LGE vs. no LGE HR 3.2; 1.9 - 5.2, p<.001
Major non-ischaemic LGE vs. ischaemic LGE HR 2.3; 1.4 - 3.7, p=0.001
No LGE                Ischaemic LGE
Minor non-ischaemic LGE                Major non-ischaemic LGE
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myocyte vacuolisation, indicating that the early T2 findings 
are at a stage when reversibility is still possible. These findings 
have important clinical implications for cancer therapy. Scally, 
et al.(17)  studied 55 patients with takotsubo cardiomyopathy 
using CMR including ultrasmall paramagnetic particles of iron 
oxide (USPIO) which localise in inflammatory macrophages. 
During the acute presentation, the USPIO signal was reduced 
in the ballooning zone by 27% (p<0.001) as compared to 
the non-ballooning zone (19% p=0.02). No enhancement was 
visible in either zone at 5 months. The authors conclude that 
takotsubo cardiomyopathy is characterised by an acute myo-
cardial macrophage inflammatory infiltrate, most marked in the 
ballooning zone. Aung, et al.(18) report on 3 920 subjects from 
the UK Biobank study who were free of overt cardiovascular 
disease but had chronic exposure to ambient air pollutants 
including particulates and nitrogen dioxide. There was an 
incremental increase in LV and RV end-diastolic and LV end-
systolic volumes with increasing exposure to particulates with a 
diameter of <2.5μm. Likewise, biventricular volumes were 
increased with higher nitrogen dioxide exposure. The authors 
conclude that air pollution is an under-recognised cardiac risk 
factor that may contribute to heart failure.
Diffusion tensor (DT) CMR is a new technique that images 
the asymmetry of water diffusion to define tissue architecture. 
Tissues such as neurons and the myocardium can be interro-
gated because of their longitudinal grain. The technique has 
recently become possible  in vivo  in humans and has been 
well validated. The three-dimensional (3D) architecture of the 
layers of the heart is now well described and is preserved 
across mammalian species suggesting that the observed 
structure has functional importance. Khalique, et al.(19)  report 
the first series of patients in whom the 3D architecture is 
deranged, these being those with situs inversus totalis (SIT, 
dextrocardia). The normal epicardial left-handed myocyte helix 
was switched to right handed at the base with a return to left 
handed at the apex. The endocardium was likewise inverted 
at the base, with variable derangement more apically. There 
was reduced strain in the SIT hearts. The long-term con-
sequences of these findings are not yet known, but it could be 
hypothesised that SIT patients may be more susceptible to 
heart failure from a second insult such as hypertension or 
infarction. Ariga, et al.(20) used DT-CMR to examine 50 patients 
with hypertrophic cardiomyopathy and report a reduction in 
the diffusion parameter called fractional anisotropy (FA) in 
patients with ventricular arrhythmias [odds ratio (OR) 2.5, 
p=0.015]. Fractional anisotropy reflects packing of the myo-
cytes and could therefore be reduced in myocardial disarray. 
While there is no direct evidence of this from histology, the 
authors conclude that connection of reduced FA with 
arrhythmias might reflect disarray. Further work is needed to 
validate this intriguing study.
Cardiovascular magnetic resonance has been used for decades 
to image the aorta and the aortic valve. Musa, et al.(21) report 
on 674 patients with severe aortic stenosis who also under-
went LGE CMR at six UK centres. The presence and extent of 
myocardial fibrosis independently predicted mortality with a 
two-fold increase in late mortality. Guala, et al.(22) report on 117 
Marfan patients in a multicentre study of outcome. During 
86 months of follow-up, the growth rate of the aortic diameter 
was 0.62 mm/year, and events were independently predicted 
by the proximal aorta longitudinal strain. The authors suggest 
that this simple measure could be included in risk assessment 
of Marfan patients.
NUCLEAR IMAGING
The current limitation of coronary computed tomography 
angiography (CCTA) is its suboptimal positive predictive value 
for the identification of myocardial ischaemia. Myocardial per-
fusion imaging (MPI) using CT could solve that limitation. 
Alessio, et al.(23) performed a dynamic contrast-enhanced car-
diac CT and  82rubidium positron emission tomography (PET) 
imaging in 34 high-risk patients. The CT-derived global myo-
cardial blood flow values correlated highly with those mea-
sured on PET (r = 0.92;  p< 0.001). In addition, the mean 
global myocardial blood flow values estimated on CT vs. PET 
were comparable (0.9 ± 0.3 vs. 1.0 ± 0.2 mL/min/g at rest and 
2.1 ±  0.7 vs. 2.0 ± 0.8 mL/min/g during stress, respectively). 
However, myocardial blood flow estimates on CT contained 
substantial individual variance with a standard error of the 
estimate of 0.44 mL/min/g. The results are promising, but 
further development is needed to improve reliability of the 
methodology at individual level as well. Furthermore, the study 
measured only global perfusion, while regional values would 
be more clinically meaningful. Another novel method to deter-
mine whether a coronary lesion is functionally significant is 
transluminal attenuation gradient (TAG) that can be measured 
using standard CCTA data. In the presence of signif icant 
coronary stenosis, luminal attenuation will decrease rapidly on 
CCTA and can be measured with TAG. In the study by Bom, 
et al.(24) transluminal attenuation gradient was compared against 
quantitative PET perfusion imaging and invasive fractional flow 
reserve (FFR) and demonstrated that TAG did not discriminate 
between vessels with or without ischaemia as defined by either 
PET or FFR. The lack of diagnostic value of TAG was related to 
the large variability of coronary luminal dimensions.
Artificial intelligence is currently a hot topic in medical image 
analysis. Machine learning, especially deep learning has been 

















using image data. Betancur, et al.(25) explored deep learning for 
automatic prediction of obstructive CAD from the polar plots 
of single photon emission CT (SPECT) MPI in 1 638 patients 
with suspected CAD. The area under the receiver operating 
characteristic curve for disease prediction by deep learning 
was higher than that of the standard analysis (per patient: 0.80 
vs. 0.78; per vessel: 0.76 vs. 0.73;  p< 0.01). The results 
demonstrate that deep learning has the potential to perform 
automatic interpretation of MPI images with at least the same 
accuracy as the standard analysis.
While the diagnostic and prognostic power of MPI has been 
well characterised, there is little evidence on how this infor-
mation should guide patient management. Patel, et al.(26) 
examined a cohort of 12 594 patients with suspected or known 
CAD undergoing PET MPI. The patients were followed-up for 
3.2 years. As expected, the low global perfusion reserve was 
associated with greater hazard of all-cause death. More 
interestingly, the patients with global perfusion reserve ≤1.8 
had a survival benefit with early revascularisation, regardless of 
the level of regional ischaemia. However, the patients with 
preserved perfusion reserve had no benefit of revascularisation 
over medical therapy (Figure 4).(26) The results are concordant 
with earlier findings showing that large ischaemia justifies 
revascularization(27,28) and extend this notion also to global 
myocardial perfusion reserve.
18F-fluoride PET imaging is gaining increasing interest in various 
conditions as an indicator of tissue microcalcification, which is 
occurring in atherosclerosis. Creager, et al.(29)  investigated in 
an ex vivo study if 18F-fluoride accumulation on atherosclerotic 
plaques is related to the development of microcalcif ications 
that are not visible on CT. In this complex study,  18F-fluoride 
signal in tissue analysis of human and mouse specimens was 
found to be clearly linked with small microcalcifications, 
which were not detected on CT. These results confirm that 
plaque mineralisation is an active process and that 18F-fluoride 
PET imaging detects coronary and carotid plaques with high-risk 
features.
In the study by Cartlidge, et al.,(30)  the degeneration of a bio-
prosthetic aortic valve was investigated using 18F-fluoride PET. 
In  ex vivo  analyses, the  18F-fluoride uptake colocalised with 
tissue degeneration on histology. In patients with aortic bio-
prostheses, increased valve  18F-fluoride uptake in PET imaging 
was associated with more rapid deterioration in valve func-
tion at 2-year follow-up. Aortic bioprosthesis dysfunction was 
detected in 10 patients and all of them showed  18F-fluoride 
uptake at baseline when the valve haemodynamics were 
normal. On multivariable analysis,  18F-fluoride uptake was the 
only independent predictor of future bioprosthetic dysfunction. 
Although a larger patient cohort is needed,  18F-fluoride PET 
imaging appears to be a promising method in predicting dys-
function of bioprosthetic valves.
FIGURE 4: Hazards for cardiac death with early revascularization compared to medical therapy based on global myocardial 
blood flow reserve by positron emission tomography myocardial perfusion imaging.
Reproduced with permission from Patel, et al.(26)
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Infection and inflammation imaging using molecular imaging 
methods is an established technique in prosthetic valve endo-
carditis and device infections. Swart, et al.(31)  investigated the 
possible confounders that may impact on the accuracy of 
18F-fluoro-deoxyglucose (FDG) PET/CT. In a multicentre study, 
160 patients with suspected prosthetic valve endocarditis and 
77 control patients were scanned. The authors found that 
low inflammatory activity (C-reactive protein <40 mg/L) – 
possibly linked with prolonged antibiotic therapy at the time 
of imaging – and use of surgical adhesives during prosthetic 
heart valve implantation were significant confounders, whereas 
recent valve implantation was not.
Another challenging population is patients with suspected 
infection of cardiac implantable electronic devices. In a study 
by Calais, et al.,(32) the diagnostic positive and negative predic-
tive values were 80% and 91% for FDG PET and 100% and 
85% for white blood cell SPECT, respectively. A prolonged 
antibiotic therapy before imaging tended to decrease the sen-
sitivity for both techniques. As FDG is not specific for inflam-
mation but for glucose uptake, more specific imaging agents 
for infection are being developed.
COMPUTED TOMOGRAPHY
Cardiac computed tomography has evolved into a one-stop-
shop imaging tool that can provide valuable diagnostic and 
prognostic information in patients with suspected or known 
CAD. Assessment of coronary artery calcium (CAC) score on 
CT can be used as a risk modifier and may guide statin therapy. 
Mitchel, et al.(33)  assessed the relative impact of statins on 
adverse cardiovascular events stratif ied by CAC scores in 
13 644 patients (mean age 50 years; 71% men) who were 
followed-up for a median of 9.4 years. Patients without CAC 
had an excellent prognosis irrespective of statin therapy, 
whereas in patients with CAC > 0, statin therapy was asso-
ciated with reduced risk of major adverse cardiovascular events 
(adjusted sub-HR 0.76; 95% CI 0.60 - 0.95; p=0.015). The effect 
of statin use on major adverse cardiovascular events was 
significantly related to the severity of CAC (p< 0.0001 for 
interaction), with a number needed to treat to prevent 1 initial 
major adverse cardiovascular event over 10 years ranging 
from 100 (when CAC was 1 - 100) - 12 (if CAC >100). 
A recent post hoc analysis of the SCOT-HEART trial demon-
strated that coronary heart disease death or non-fatal MI was 
three times more frequent in patients with high-risk plaque 
features (positive remodelling or low attenuation plaque) and 
was twice as frequent in those with obstructive CAD.(34) 
However, these associations were not independent of CAC 
score, a surrogate measure of atherosclerosis burden.
The investigators of the PROMISE Trial assessed the preva-
lence and clinical predictors of high-risk CAD (defined as left 
main stenosis or either ≥50% stenosis or ≥70% stenosis of 3 
vessels or 2-vessel CAD involving the proximal left anterior 
descending artery).(35)  High-risk CAD was identified in 6.6% 
(≥50% stenosis) and 2.4% (≥70% stenosis) of patients. Variables 
predictive of high-risk CAD included family history of prema-
ture CAD, age, male sex, lower glomerular filtration rate, 
diabetes mellitus, elevated systolic blood pressure, and angina. 
High-risk CAD was associated with more frequent invasive 
interventions and adverse events as compared to non-high-
risk CAD.
An intriguing study has investigated the prognostic value of 
combined information of lesion-specific ischaemia (FFR) and 
adverse plaque features by CCTA.(36)  The authors evaluated 
772 vessels (299 patients) by both CCTA and invasive FFR 
measurement. Interestingly, the presence of ≥3 high-risk 
plaque features was independently associated with clinical 
events in the FFR > 0.80 group, but not in the FFR ≤0.80 group. 
It seems that the integration of both lesion-specific ischaemia 
and CT plaque features may provide better prognostic strati-
fication than either individual component alone, especially in 
patients with n FFR >0.80.
Using computational fluid dynamics simulations, CT is now 
capable to provide non-invasive FFR measurements. A study by 
Norgaard, et al.(37)  assessed real-world clinical outcomes fol-
lowing a diagnostic strategy including first-line coronary CTA 
with selective FFRCT testing. The study reviewed the results of 
3 674 consecutive patients with stable chest pain evaluated 
with CTA and FFRCT  testing. The presence of intermediate-
range CAD and FFRCT >0.80 was associated with favourable 
clinical outcomes similar to the prognosis in patients without 
or with minimal evidence of CAD. Beyond FFRCT simulation, 
stress CT perfusion has emerged as a potential strategy to 
acquire anatomic and functional evaluation of CAD. Whole 
heart coverage CT scanners have become readily available, 
which allow a more robust stress CT MPI (CTP). The diagnostic 
accuracy of latest scanner generation was tested by Pontone, 
et al.(38) in 100 intermediate- to high-risk symptomatic patients 
with suspected CAD. CCTA alone demonstrated a sensiti-
vity, specificity, negative predictive value, positive predictive 
value, and accuracy of 98%, 76%, 99%, 63%, and 83%, 
respectively. Combining CCTA with stress CTP, these values 
were 91%, 94%, 96%, 86%, and 93%, respectively, with a 
significant improvement in specificity, positive predictive value, 
and accuracy. The mean effective radiation dose for CCTA and 

















Patients with diabetes are a high-risk patient cohort for adverse 
cardiovascular outcomes. The PROMISE Trial investigators 
assessed whether a diagnostic strategy based on CCTA is 
superior to functional stress testing in reducing cardiovascular 
death or MI among symptomatic patients with diabetes 
[n = 1908 (21%)] vs. patients without diabetes [n = 7058 
(79%)].(39)  Patients with diabetes who underwent CCTA had 
a lower risk of cardiovascular death or MI compared with 
functional stress testing [CCTA: 1.1% (10 of 936) vs. stress 
testing: 2.6% (25 of 972); adjusted HR 0.38; 95% CI 0.18 - 
0.79;  p=0.01]. Another study also including individuals with 
diabetes, investigated the rate and extent of plaque progres-
sion, changes in plaque features, and clinical predictors of 
plaque progression.(40)  A total of 1 602 patients who under-
went serial CCTA (median scan interval 3.8 years) were 
enrolled and analysed from the PARADIGM (Progression of 
Atherosclerotic Plaque Determined by Computed Tomo-
graphic Angiography Imaging) trial.(41)  Diabetes was an inde-
pendent risk factor for plaque progression (OR 1.526, 95% 
CI 1.100 - 2.118; p=0.011).
A more precise risk assessment that incorporates the detec-
tion of coronary inflammation would allow personalised 
medical interventions. Novel analytical techniques such as peri-
vascular fat attenuation index or plaque-based radiomics may 
facilitate the detection and quantif ication of pericoronary 
inflammation and atherosclerotic plaque activity.(42,43) An inno-
vative study by Oikonomou, et al.(44)  demonstrated that arti-
ficial intelligence-powered pericoronary fat radiomic profile 
(FRP) analysis significantly improved major adverse cardio-
vascular events prediction beyond traditional risk stratification 
that included risk factors, CAC, coronary stenosis, and high-risk 
plaque features on CCTA in the SCOT-HEART trial (Figure 5). 
The authors conclude that FRP leads to a significant improve-
ment of cardiac risk prediction over and above the current 
state-of-the-art, which might help to identify patients with 
elevated residual risk for cardiovascular events.
ADVANCED IMAGING, FUSION IMAGING, 
AND APPLIED ARTIFICIAL INTELLIGENCE 
IN IMAGING
Cardiovascular (invasive and non-invasive) imaging is devel-
oping at an ultrafast pace and the clinician of today gets daily 
confronted with different imaging modalities, with major tech-
nological developments, but also fusion imaging and the intro-
duction of artificial intelligence and machine learning. From a 
clinical perspective, the cardiovascular imager of tomorrow 
needs to be familiar with the different modalities, and when to 
apply which technique in which clinical scenario. A dedicated 
task force of The European Association of Cardiovascular 
Imaging (part of the ESC) has published a statement on the 
organisation of multimodality imaging services in cardiology, 
the use of the different modalities as well as training and 
research in the multimodality era.(1)
Ramos, et al.(45) used an animal (mice) model to study myocar-
dial healing after infarction using serial imaging (7 days and 
21 days post-infarction) with 3T magnetic resonance imaging 
(MRI) and a 19F/1H surface coil. Injected 19F-perfluorocarbon 
nanoparticles were used to evaluate recruitment of inflam-
matory cells (e.g. macrophages), and an injected gadolinium-
based elastin-binding contrast agent was used to assess elastin 
content. The combination of these imaging techniques enabled 
assessing the time course of the remodelling and healing 
process, as well as scar development.
Engel, et al.(46) evaluated 25 patients with either stable CAD or 
presenting with suspected ACS using a non-invasive albumin-
binding probe gadofosveset-enhanced CMR, as well invasive 
coronary angiography and optical coherence tomography 
(OCT). CMR was performed twice: prior to baseline exami-
nation and 24  hours after gadofosveset-trisodium administra-
tion. The patients with suspected ACS revealed significantly 
higher signal enhancement on CMR following gadofosveset-
trisodium application on the segments containing a culprit 
lesion as compared to patients with stable CAD. On OCT, 
these patients presented with thin-cap fibroatheroma. The 
novel CMR approach may enable early detection of patients 
with potential ACS.
Several articles in the field of multimodality and fusion imaging 
are worth highlighting. Mitral annular calcification is observed in 
patients with mitral regurgitation/stenosis and is important 
when transcatheter valve replacement is considered. To better 
understand pathophysiology, Massera, et al.(47)  performed CT 
calcium score of the mitral annulus, as well as PET with 
18F-fluoride (calcification activity) and  18F-FDG (inflammation 
activity) in 104 patients. Mitral annular calcification was noted 
in 35 patients who exhibited increased  18F-fluoride uptake 
and FDG uptake, suggesting increased local calcification and 
inflammation.
Fernandez-Friera, et al.(48) used hybrid FDG PET/MRI to assess 
arterial vascular plaques in middle-aged individuals (n=755). 
With this sophisticated imaging technology, the authors evalu-
ated multi-territorial atherosclerosis (carotid, aortic, and ilio-
femoral arteries); plaques were present on MRI in 90.1% 
(73.9% femorals, 55.8% iliacs, and 53.1% carotids), whereas 
inflammation was observed on PET in 48.2% of individuals 
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(24.4% femorals, 19.3% aorta, 15.8% carotids, and 9.3% iliacs). 
The authors concluded that arterial inflammation is noted in 
50% of arterial plaques in middle-aged individuals.
The current status of artificial intelligence and machine learning 
was elegantly reviewed by Al’Aref, et al.(49) With the increasing 
digitisation of data making big datasets available and easier to 
process, machine learning has enabled autonomously acquiring 
knowledge by the extraction of patterns from these large 
datasets. Particularly in cardiology, machine learning has been 
rapidly adopted in various fields, to permit automated analysis 
of electrocardiograms and imaging (echocardiography, nuclear 
perfusion imaging, and CCTA) (Figure 6).
Another excellent review was published by Krittanawong, 
et al.(2) providing further insight in deep learning. This is a branch 
FIGURE 5: Radiomic phenotyping of coronary perivascular adipose tissue.
(A) The perivascular adipose tissue (PVAT) of the right (RCA) and left (LCA) coronary was segmented and used to calculate a number of shape-, 
attenuation-, and texture-related statistics. (B) Correlation plot of all 1 391 stable radiomic features in the SCOT-HEART population (n = 1575 
patients), with hierarchical clustering revealing distinct clusters of radiomic variance. (C) Heatmap of scaled radiomic features in the SCOT-
HEART population revealing between-patient variance across the cohort. Reproduced with permission from Oikonomou, et al.(44)
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of artificial intelligence, which combines computer science, 
statistics and decision theory to discover patterns in complex 
and big data. Casaclang-Verzosa, et al.(50)  applied machine 
learning to advanced network analysis to demonstrate auto-
mated assessment of LV (hypertrophy) in response to aortic 
valve stenosis from echocardiographic images. Finally, Zhang, 
et al.(51) published original research on the use of deep learning 
to analyse echocardiographic data (n = 14 035 echocardio-
grams), in a fully automated fashion, including (i) view identi-
fication, (ii) image segmentation, (iii) quantification of structure 
and function, and (iv) disease detection. Specifically, con-
volutional neural networks were trained to detect hypertrophic 
cardiomyopathy, cardiac amyloidosis, and pulmonary arterial 
hypertension with respective C statistics of 0.93, 0.87, and 0.85.
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FIGURE 6: Machine learning algorithms applied to echocardiography.
Echocardiographic data are post-processed to automate many processes performed in clinical practice by cardiologists and sonographers, such 
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